Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93175 citas

 
 
<< anterior 21 a 40 de 96 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Bonafont X, Pontón JL. Noves evidències en l'ús dels factors estimuladors de l'eritropoesi. Butlletí d'Informació Terapèutica 2007;19:41-5. [Ref.ID 82211]
22. Cita con resumen
Dudzinski DM, Kesselheim AS. Scientific and legal viability of follow-on protein drugs. N Engl J Med 2008;358:843-9. [Ref.ID 82210]
23. Cita con resumen
Anónimo. Amgen shows little growth despite lower R&D costs. Scrip 2008;3331:11. [Ref.ID 82106]
24.
Sung L, Nathan PC, Alibhai SMH, Tomlinson GA, Beyene J. Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med 2007;147:400-11. [Ref.ID 81105]
25.
Thompson DF, Montarella KE. Drug-induced sweet's syndrome. Ann Pharmacother 2007;41:802-11. [Ref.ID 80140]
26. Cita con resumen
Anónimo. Global market saw year of tumult with pockets of growth. Scrip 2007;3252:15. [Ref.ID 79872]
27. Cita con resumen
Anónimo. Global blockbuster model is far from dead, says IMS. Scrip 2006;3147:14. [Ref.ID 76617]
28.
Zohlnhöfer D, Ott I, Mehilli J, Schömig K, Michalk F, Ibrahim T, Meisetschläger G, von Wedel J, Bollwein H, Seyfarth M, Dirschinger J, Schmitt C, Schwaiger M, Kastrati A, Schömig A, for the REVIVAL-2 Investigators. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction. A randomized controlled trial. JAMA 2006;295:1003-10. [Ref.ID 76263]
32.
Löwenberg B, van Putten W, Theobald M, Gmür J, Verdonck L, Sonneveld P, Fey M, Schouten H, de Greef G, Ferrant A, Kovacsovics T, Gratwohl A, Daenen S, Huijgens P, Boogaerts M, for the Dutch-Belgian hemato-Oncology (HOVON) Cooperative Group and the Swiss Group for Clinical Cancer Research. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003;349:743-52. [Ref.ID 67208]
33. Cita con resumen
Anónimo. 30 new chemical entities in 2002. Scrip 2003;2823:26. [Ref.ID 65025]
34. Cita con resumen
Dieckgraefe BK, Korzenik JR. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 2002;360:1478-80. [Ref.ID 63991]
36.Tiene citas relacionadas
Green M. Pegfilgrastim: viewpoint. Drugs 2002;62:1214-5. [Ref.ID 61953]
37.Tiene citas relacionadas
Holmes FA. Pegfilgrastim: viewpoint. Drugs 2002;62:1214. [Ref.ID 61952]
38.Tiene citas relacionadas
Curran MP, Goa KL. Pegfilgrastim. Drugs 2002;62:1207-13. [Ref.ID 61951]
39. Cita con resumen
Anónimo. Pegfilgrastim (Neulasta) for prevention of febrile neutropenia. Med Lett Drugs Ther 2002;44:44-5. [Ref.ID 61941]
40. Cita con resumen
Mead GM. Management of oral mucositis associated with cancer chemotherapy. Lancet 2002;359:815-6. [Ref.ID 61163]
Seleccionar todas
 
<< anterior 21 a 40 de 96 siguiente >>